Decreased mortality in cancer patients treated for proximal deep vein thrombosis with low-molecular-weight heparin as compared with unfractionated heparin

被引：0

作者：

Pineo, GF ^{[1
]}

Hull, RD ^{[1
]}

Raskob, GE ^{[1
]}

Brant, RF ^{[1
]}

Green, D ^{[1
]}

机构：

[1] UNIV CALGARY, CALGARY, AB T2N 1N4, CANADA

来源：

THROMBOSIS AND HAEMOSTASIS | 1997年

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：O1566 / O1566

页数：1

共 50 条

[21] Low-molecular-weight heparin and unfractionated heparin in prophylaxis against deep vein thrombosis in critically ill patients undergoing major surgery
De, Anushtup
Roy, Prabal
Garg, Vinod K.
Pandey, Narendra K.
BLOOD COAGULATION & FIBRINOLYSIS, 2010, 21 (01) : 57 - 61
[22] COMPARISON OF SUBCUTANEOUS LOW-MOLECULAR-WEIGHT HEPARIN WITH INTRAVENOUS STANDARD HEPARIN IN PROXIMAL DEEP-VEIN THROMBOSIS
PRANDONI, P
LENSING, AWA
BULLER, HR
CARTA, M
COGO, A
VIGO, M
CASARA, D
RUOL, A
TENCATE, JW
LANCET, 1992, 339 (8791): : 441 - 445
[23] Cost-minimization analysis of low-molecular-weight heparin (dalteparin) compared to unfractionated heparin for inpatient treatment of cancer patients with deep venous thrombosis
Elenir B. C. Avritscher
Scott B. Cantor
Ya-Chen T. Shih
Carmelita P. Escalante
Edgardo Rivera
Linda S. Elting
Supportive Care in Cancer, 2004, 12 : 531 - 536
[24] Cost-minimization analysis of low-molecular-weight heparin (dalteparin) compared to unfractionated heparin for inpatient treatment of cancer patients with deep venous thrombosis
Avritscher, EBC
Cantor, SB
Shih, YCT
Escalante, CP
Rivera, E
Elting, LS
SUPPORTIVE CARE IN CANCER, 2004, 12 (07) : 531 - 536
[25] Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of patients with pulmonary embolism and underlying proximal deep-vein thrombosis
Hull, RD
Raskob, GE
Brant, RF
Pineo, GF
THROMBOSIS AND HAEMOSTASIS, 1999, : 7 - 7
[26] Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of patients with pulmonary embolism and underlying proximal deep vein thrombosis.
Hull, RD
Raskob, GE
Brant, RF
Pineo, GF
Elliott, G
Stein, PD
Gottschalk, A
Valentine, KA
Mah, AF
BLOOD, 1998, 92 (10) : 120B - 120B
[27] A RANDOMIZED TRIAL OF SUBCUTANEOUS LOW-MOLECULAR-WEIGHT HEPARIN (CY-216) COMPARED WITH INTRAVENOUS UNFRACTIONATED HEPARIN IN THE TREATMENT OF DEEP-VEIN THROMBOSIS
DUROUX, P
THROMBOSIS AND HAEMOSTASIS, 1991, 65 (03) : 251 - 256
[28] Comparative effects of unfractionated heparin and a low-molecular-weight heparin on antithrombin activity in the treatment of deep-vein thrombosis.
Mayuga, M
Ahmad, S
Hoppensteadt, DA
Frapaise, FX
Fareed, J
BLOOD, 2001, 98 (11) : 270A - 270A
[29] Low-molecular-weight heparins versus unfractionated heparin in the treatment of deep vein thrombosis and pulmonary embolism
Merli, Geno J.
Kind, Ludwig A.
American Journal of Physical Medicine and Rehabilitation, 2000, 79 (5 SUPPL.):
[30] Low-molecular-weight heparins versus unfractionated heparin in the treatment of deep vein thrombosis and pulmonary embolism
Merli, GJ
AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 2000, 79 (05) : S9 - S16

← 1 2 3 4 5 →